Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for LFST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -50.88M
March 31, 2026 -73.04M
December 31, 2025 -1.91M
September 30, 2025 -2.022M
June 30, 2025 -2.048M
March 31, 2025 -9.975M
December 31, 2024 -4.059M
September 30, 2024 -2.025M
June 30, 2024 -1.432M
March 31, 2024 -2.431M
December 31, 2023 30.84M
September 30, 2023 -1.849M
Date Value
June 30, 2023 23.33M
March 31, 2023 -4.888M
December 31, 2022 12.66M
September 30, 2022 8.192M
June 30, 2022 12.90M
March 31, 2022 13.51M
December 31, 2021 -15.17M
September 30, 2021 -6.27M
June 30, 2021 312.70M
March 31, 2021 22.59M
December 31, 2020 134.24M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
DaVita, Inc. -269.89M
Progyny, Inc. -32.89M
Quest Diagnostics, Inc. -229.00M
Aveanna Healthcare Holdings, Inc. 2.361M
Acadia Healthcare Co., Inc. -116.57M